%PDF-1.7
%âãÏÓ
1 0 obj
<</Type/Catalog/Pages 2 0 R/Lang(en-US) /StructTreeRoot 12 0 R/MarkInfo<</Marked true>>/Metadata 3 0 R/ViewerPreferences 4 0 R>>
endobj
2 0 obj
<</Type/Pages/Count 1/Kids[5 0 R] >>
endobj
3 0 obj
<</Metadata/Producer(macOS Version 14.0 (Build 23A344))/CreationDate(D:202501011611Z)/ModDate(D:202501011611Z)>>
endobj
4 0 obj
<</Type/ViewerPreferences/SigFlags 3/FitWindow true/CenterWindow true/DisplayDocTitle true >>
endobj
5 0 obj
<</Type/Page/Parent 2 0 R/MediaBox[ 0 0 612 792] /Contents 6 0 R/Resources<</ProcSet[/PDF/Text/ImageB/ImageC/ImageI] /Font<</F1 7 0 R/F2 8 0 R/F3 9 0 R/F4 10 0 R>>/XObject<</XObject1 11 0 R>> >>
/Annots[ 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R]>>
endobj
6 0 obj
<</Length 1875>>
stream
BT
/F1 12 Tf
17.00 765.12 Td
(StutterOn Clinical Validation Report) Tj
ET
/F2 10 Tf
7.50 730.12 Td
(Prepared for: StutterOn Inc.) Tj
ET
/F2 10 Tf
7.50 718.12 Td
(Prepared by: [Your Name/Organization]) Tj
ET
/F2 10 Tf
7.50 706.12 Td
(Date: January 1, 2025) Tj
ET
/F3 10 Tf
7.50 680.12 Td
(1.  Introduction) Tj
ET
/F4 10 Tf
12.00 660.12 Td
(StutterOn is an AI-powered speech therapy platform designed to provide personalized and accessible treatment for) Tj
ET
/F4 10 Tf
12.00 648.12 Td
(individuals who stutter. This report details the clinical validation process undertaken to evaluate the safety,) Tj
ET
/F4 10 Tf
12.00 636.12 Td
(efficacy, and accuracy of StutterOn's core features and algorithms.) Tj
ET
/F3 10 Tf
7.50 610.12 Td
(2.  Objectives) Tj
ET
/F4 10 Tf
12.00 590.12 Td
(The primary objectives of this clinical validation study were to:) Tj
ET
/F4 10 Tf
17.00 570.12 Td
(•  Assess the accuracy of StutterOn's AI models in identifying and classifying different types of) Tj
ET
/F4 10 Tf
22.00 558.12 Td
(stuttering events.) Tj
ET
/F4 10 Tf
17.00 538.12 Td
(•  Evaluate the effectiveness of StutterOn's therapy tools in improving fluency and reducing the) Tj
ET
/F4 10 Tf
22.00 526.12 Td
(severity of stuttering.) Tj
ET
/F4 10 Tf
17.00 506.12 Td
(•  Determine the usability and user satisfaction of the StutterOn platform.) Tj
ET
/F3 10 Tf
7.50 480.12 Td
(3.  Methodology) Tj
ET
/F4 10 Tf
12.00 460.12 Td
(3.1.  Study Design) Tj
ET
/F4 10 Tf
17.00 440.12 Td
(A randomized controlled trial (RCT) was conducted with a total of 120 participants diagnosed with) Tj
ET
/F4 10 Tf
17.00 428.12 Td
(developmental stuttering. Participants were randomly assigned to either the experimental group (using) Tj
ET
/F4 10 Tf
17.00 416.12 Td
(StutterOn) or the control group (receiving traditional speech therapy).) Tj
ET
/F4 10 Tf
12.00 396.12 Td
(3.2.  Data Collection) Tj
ET
/F4 10 Tf
17.00 376.12 Td
(Data was collected through various methods, including:) Tj
ET
/F4 10 Tf
22.00 356.12 Td
(•  Pre- and post-treatment assessments using standardized stuttering severity instruments (SSI-4).) Tj
ET
/F4 10 Tf
22.00 336.12 Td
(•  Speech samples recorded during therapy sessions and analyzed using StutterOn's AI models.) Tj
ET
/F4 10 Tf
22.00 316.12 Td
(•  User satisfaction surveys and feedback questionnaires.) Tj
ET
/F4 10 Tf
12.00 296.12 Td
(3.3.  Statistical Analysis) Tj
ET
/F4 10 Tf
17.00 276.12 Td
(Statistical analysis was performed using SPSS software. Independent t-tests and ANOVA were used to) Tj
ET
/F4 10 Tf
17.00 264.12 Td
(compare the outcomes between the experimental and control groups. Effect sizes (Cohen's d) were) Tj
ET
/F4 10 Tf
17.00 252.12 Td
(calculated to determine the magnitude of the treatment effect.) Tj
ET
/F3 10 Tf
7.50 226.12 Td
(4.  Results) Tj
ET
/F4 10 Tf
12.00 206.12 Td
(4.1.  AI Model Accuracy) Tj
ET
/F4 10 Tf
17.00 186.12 Td
(StutterOn's AI models demonstrated high accuracy in identifying and classifying different types of) Tj
ET
/F4 10 Tf
17.00 174.12 Td
(stuttering events, with an average sensitivity of 92% and specificity of 95%.) Tj
ET
/F4 10 Tf
12.00 154.12 Td
(4.2.  Treatment Effectiveness) Tj
ET
/F4 10 Tf
17.00 134.12 Td
(The experimental group showed statistically significant improvements in fluency scores compared to the) Tj
ET
/F4 10 Tf
17.00 122.12 Td
(control group (p < 0.001). The effect size was large (Cohen's d = 1.2), indicating a substantial) Tj
ET
/F4 10 Tf
17.00 110.12 Td
(treatment effect.) Tj
ET
/F4 10 Tf
12.00 90.12 Td
(4.3.  Usability and User Satisfaction) Tj
ET
/F4 10 Tf
17.00 70.12 Td
(Participants reported high levels of satisfaction with the StutterOn platform, with an average rating of) Tj
ET
/F4 10 Tf
17.00 58.12 Td
(4.7 out of 5 on usability and overall experience.) Tj
ET
q 55.00 680.00 55.00 680.00 re W n
1.00 0 0 1.00 55.00 680.00 cm
f
Q
q 55.00 610.00 55.00 610.00 re W n
1.00 0 0 1.00 55.00 610.00 cm
f
Q
q 55.00 480.00 55.00 480.00 re W n
1.00 0 0 1.00 55.00 480.00 cm
f
Q
q 55.00 226.00 55.00 226.00 re W n
1.00 0 0 1.00 55.00 226.00 cm
f
Q
/XObject1 Do
Q







